13F HOLDINGS REPORT
Aisling Capital Management LP
Quarter ended Q1 2023 · Filed February 9, 2023 · Accession 0001766721-23-000001
Total Value
$151.5M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BridgeBio Pharma Inc. (BBIO) | BBIO | 6,068,125 | $46.2M | 30.53% |
| 2 | Verona Pharma plc (VRNA) | 925050106 | 1,332,485 | $34.8M | 22.99% |
| 3 | Syndax Pharmaceuticals, Inc. (SNDX) | SNDX | 1,025,000 | $26.1M | 17.22% |
| 4 | Monte Rosa Therapeutics Inc. (GLUE) | GLUE | 1,472,331 | $11.2M | 7.40% |
| 5 | Aclaris Theraputics Inc. (ACRS) | ACRS | 434,455 | $6.8M | 4.52% |
| 6 | Biomea Fusion Inc. (BMEA) | BMEA | 798,757 | $6.7M | 4.45% |
| 7 | Poseida Therapeutics Inc. (PSTX) | 73730P108 | 1,043,267 | $5.5M | 3.65% |
| 8 | Nuvation Bio Inc. (NUVB) | NUVB | 2,541,009 | $4.9M | 3.22% |
| 9 | Elevation Oncology Inc. (ELEV) | 28623U101 | 2,834,910 | $2.7M | 1.78% |
| 10 | Reneo Pharmaceuticals Inc. (RPHM) | 75974E103 | 886,075 | $2.1M | 1.36% |
| 11 | Spruce Biosciences, Inc. (SPRB) | SPRB | 1,205,511 | $1.3M | 0.87% |
| 12 | Marker Therapeutics, Inc. (MRKR) | MRKR | 3,142,857 | $848,571 | 0.56% |
| 13 | Aeglea Biotherapeutics Inc. (AGLE) | 00773J103 | 1,691,151 | $761,018 | 0.50% |
| 14 | AVROBIO, Inc. (AVRO) | 05455M100 | 1,009,779 | $716,943 | 0.47% |
| 15 | Viracta Therapeutics Inc. (VIRX) | 92765F108 | 288,571 | $421,314 | 0.28% |
| 16 | Atreca Inc. (BCEL) | 04965G109 | 387,653 | $310,510 | 0.20% |